Xylocaine- Mpf (lidocaine Hcl ) Injection, Solution
Product Images NDC 51662-1604

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Xylocaine- Mpf (lidocaine Hcl ) (NDC 51662-1604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Labeling (51662 1604 2 Pouch Labeling Sept 2022)

Pouch Labeling (51662 1604 2 Pouch Labeling Sept 2022)
XYLOCAINE®- MPF is a Lidocaine HCL injection with a concentration of 2% and a volume of 100mg/SnL in a small vial. The product label mentions usage in nerve block procedures including caudal and epidural. There are some unreadable characters and numbers on the label. The product is only available with a prescription.*
FDA Label Image

Case Labeling (51662 1604 3 Case Labeling Sept 2022)

Case Labeling (51662 1604 3 Case Labeling Sept 2022)
XYLOCAINE®- MPF is a local anesthetic injection with Lidocaine. It is available in a 5ml vial and a case contains 25 vials. The provided text also contains some random characters and is not clear. Please provide a new text for evaluation.*
FDA Label Image

Rfid Labeling (51662 1604 3 Serialized Rfid Labeling Sept 2022)

FDA Label Image
FDA Label Image

Precautions (Precautions)

Precautions (Precautions)
This is a table describing various classes of drugs including nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. The table also provides examples of drugs within each class. Some examples include nitric oxide and nitroglycerin for nitrates/nitrites, lidocaine and procaine for local anesthetics, and chloroquine and primaquine for antimalarials.*
FDA Label Image

S1 (Structure 1)

FDA Label Image

S2 (Structure 2)

FDA Label Image

Vial Label (Vial Label Sept 2022)

Vial Label (Vial Label Sept 2022)
This is a description of a medication with the NDC number 63323-495-04. The medication is sterile and nonpyrogenic and contains lidocaine HCl Injection with 2% of 100mg per Sml. It can be resterilized by autoclaving but should not be used if the solution is discolored or precipitated. The medication is indicated for infiltration and nerve block including caudal and epidural use. It comes in a 5 mL single-dose vial and is available by prescription only from the manufacturer's website, www.fresenius-kabi.com/us.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.